Revivicor

GPTKB entity

Statements (26)
Predicate Object
gptkbp:instance_of gptkb:Company
gptkbp:acquisition acquired by United Therapeutics Corporation
gptkbp:clinical_trial xenotransplantation trials
gptkbp:collaborations scientific research institutions
with various universities
gptkbp:focus xenotransplantation
gptkbp:founded gptkb:2000
gptkbp:founder gptkb:Dr._John_A._Mc_Donald
gptkbp:goal develop pig organs for human transplantation
gptkbp:headquarters gptkb:Huntsville,_Alabama
https://www.w3.org/2000/01/rdf-schema#label Revivicor
gptkbp:impact organ transplant field
gptkbp:innovation biomedical advancements
gptkbp:invention biotechnology patents
gptkbp:leadership experienced biotech executives
gptkbp:mission address organ shortage crisis
gptkbp:partnership gptkb:University_of_Alabama_at_Birmingham
gptkbp:products genetically modified pigs
gptkbp:publishes gptkb:academic_journal
gptkbp:receives_funding_from venture capital investments
gptkbp:regulatory_compliance FDA approval process
gptkbp:research_areas transplant immunology
gptkbp:technology genetic engineering
gptkbp:vision transform organ transplantation
gptkbp:bfsParent gptkb:United_Therapeutics_Corporation
gptkbp:bfsLayer 6